Latest Conference Articles

May 24th 2012, 1:20pm

AACE Annual Scientific and Clinical Congress

Photos taken from the AACE 21st Annual Scientific and Clinical Congress held at the Pennsylvania Convention Center, from May 23-27, 2012.

May 24th 2012, 12:48pm

AACE Annual Scientific and Clinical Congress

A look at two poster presentations from the AACE meeting focusing on insular carcinoma and medullary thyroid cancer.

May 17th 2012, 1:45pm

ASCO Annual Meeting

Dr. Michael Rotkowitz, from Cancer Treatment Centers of America, on the Dabrafenib Plus Trametinib Combination for Melanoma

May 16th 2012, 2:06pm

ASCO Annual Meeting

Combined neoadjuvant treatment with abiraterone acetate (Zytiga) plus standard hormonal therapy before prostatectomy eradicated or nearly eradicated tumors in 34% of patients with localized high-risk prostate cancer.

May 16th 2012, 2:05pm

ASCO Annual Meeting

A combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib has shown promising activity in patients with advanced melanoma.

May 16th 2012, 2:04pm

ASCO Annual Meeting

Olanzapine, an antipsychotic medication that is often used off-label, has proved highly effective in controlling breakthrough chemotherapy-induced nausea and vomiting.

May 16th 2012, 2:04pm

ASCO Annual Meeting

Dr. Leonard Gomella, from Jefferson Kimmel Cancer Center, on Neoadjuvant Hormonal Therapy Combined With Abiraterone Acetate

May 16th 2012, 2:02pm

ASCO Annual Meeting

Dr. Paul Chapman, from Memorial Sloan-Kettering Cancer Center, on Combining BRAF and MEK Inhibitors for Advanced Melanoma

May 16th 2012, 2:01pm

ASCO Annual Meeting

Dr. Maurie Markman, Cancer Treatment Centers of America, on Primary Care Physician Awareness of Long-Term Chemotherapy Side Effects

May 16th 2012, 2:01pm

ASCO Annual Meeting

Many primary care providers and some oncologists are unaware of the long-term effects of four chemotherapy drugs used to treat two of the most common forms of cancer.

May 16th 2012, 2:00pm

ASCO Annual Meeting

Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL

May 16th 2012, 2:00pm

ASCO Annual Meeting

Targeting the ALK gene with the oral agent crizotinib slowed or eliminated signs of tumor growth in pediatric patients with aggressive forms of neuroblastoma, ALCL, and IMTs.

May 16th 2012, 12:02pm

ASCO Annual Meeting

Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

May 10th 2012, 1:40pm

Oncology Nursing Society Congress

Five nurses discuss the value of the Oncology Nursing Society (ONS) Annual Congress, which is the largest meeting held specifically for oncology nurses.

May 8th 2012, 10:38am

Oncology Nursing Society Congress

The Oncology Nursing Society (ONS) 37th Annual Congress video highlights, from OncLive TV.

May 7th 2012, 1:29pm

Oncology Nursing Society Congress

The Oncology Nursing Society (ONS) 37th Annual Congress Picture Slideshow.

May 7th 2012, 12:40pm

Oncology Nursing Society Congress

A recap of our coverage from the Oncology Nursing Society 37th Annual Congress, in New Orleans, where thousands of oncology nurses gathered and shared valuable clinical insights.

May 7th 2012, 12:25pm

Oncology Nursing Society Congress

Mary Gullatte, the president of the Oncology Nursing Society, Discusses Nursing Shortages

May 7th 2012, 12:24pm

Oncology Nursing Society Congress

Carol Bush, BS, RN, from the The University of Kansas Cancer Center, on the Midwest Cancer Alliance Telehealth Network

May 7th 2012, 12:13pm

Oncology Nursing Society Congress

Universal tumor testing and a detailed personal and family history assessment are recommended for all patients with newly diagnosed colorectal cancer.